Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 19 of 19 entries
Sorted by: Best Match Show Resources per page
Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease.

Annals of intensive care

Drolz A, Horvatits T, Roedl K, Rutter K, Brunner R, Zauner C, Schellongowski P, Heinz G, Funk GC, Trauner M, Schneeweiss B, Fuhrmann V.
PMID: 29675709
Ann Intensive Care. 2018 Apr 19;8(1):48. doi: 10.1186/s13613-018-0391-9.

BACKGROUND: Acid-base disturbances are frequently observed in critically ill patients at the intensive care unit. To our knowledge, the acid-base profile of patients with acute-on-chronic liver failure (ACLF) has not been evaluated and compared to critically ill patients without...

Cite
Drolz A, Horvatits T, Roedl K, et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Ann Intensive Care. 2018;8(1):48doi: 10.1186/s13613-018-0391-9.
Drolz, A., Horvatits, T., Roedl, K., Rutter, K., Brunner, R., Zauner, C., Schellongowski, P., Heinz, G., Funk, G. C., Trauner, M., Schneeweiss, B., & Fuhrmann, V. (2018). Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of intensive care, 8(1), 48. https://doi.org/10.1186/s13613-018-0391-9
Drolz, Andreas, et al. "Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease." Annals of intensive care vol. 8,1 (2018): 48. doi: https://doi.org/10.1186/s13613-018-0391-9
Drolz A, Horvatits T, Roedl K, Rutter K, Brunner R, Zauner C, Schellongowski P, Heinz G, Funk GC, Trauner M, Schneeweiss B, Fuhrmann V. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Ann Intensive Care. 2018 Apr 19;8(1):48. doi: 10.1186/s13613-018-0391-9. PMID: 29675709; PMCID: PMC5908779.
Copy Download .nbib Format: NLM
A bi-centric experience of extracorporeal carbon dioxide removal (ECCO.

Artificial organs

Wohlfarth P, Schellongowski P, Staudinger T, Rabitsch W, Hermann A, Buchtele N, Turki AT, Tzalavras A, Liebregts T.
PMID: 33533502
Artif Organs. 2021 Aug;45(8):903-910. doi: 10.1111/aor.13931. Epub 2021 May 04.

Acute respiratory failure (ARF) is the main reason for ICU admission following allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal CO

Cite
Wohlfarth P, Schellongowski P, Staudinger T, et al. A bi-centric experience of extracorporeal carbon dioxide removal (ECCO. Artif Organs. 2021;45(8):903-910doi: 10.1111/aor.13931.
Wohlfarth, P., Schellongowski, P., Staudinger, T., Rabitsch, W., Hermann, A., Buchtele, N., Turki, A. T., Tzalavras, A., & Liebregts, T. (2021). A bi-centric experience of extracorporeal carbon dioxide removal (ECCO. Artificial organs, 45(8), 903-910. https://doi.org/10.1111/aor.13931
Wohlfarth, Philipp, et al. "A bi-centric experience of extracorporeal carbon dioxide removal (ECCO." Artificial organs vol. 45,8 (2021): 903-910. doi: https://doi.org/10.1111/aor.13931
Wohlfarth P, Schellongowski P, Staudinger T, Rabitsch W, Hermann A, Buchtele N, Turki AT, Tzalavras A, Liebregts T. A bi-centric experience of extracorporeal carbon dioxide removal (ECCO. Artif Organs. 2021 Aug;45(8):903-910. doi: 10.1111/aor.13931. Epub 2021 May 04. PMID: 33533502; PMCID: PMC8360202.
Copy Download .nbib Format: NLM
Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status.

Annals of intensive care

Mokart D, Darmon M, Schellongowski P, Pickkers P, Soares M, Rello J, Bauer PR, van de Louw A, Lemiale V, Taccone FS, Martin-Loeches I, Salluh J, Rusinova K, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Landburg PP, Bukan RB, Pène F, Metaxa V, Burghi G, Saillard C, Nielsen LB, Canet E, Bisbal M, Azoulay E.
PMID: 33090310
Ann Intensive Care. 2020 Oct 22;10(1):146. doi: 10.1186/s13613-020-00764-7.

BACKGROUND: The impact of neutropenia in critically ill immunocompromised patients admitted in a context of acute respiratory failure (ARF) remains uncertain. The primary objective was to assess the prognostic impact of neutropenia on outcomes of these patients. Secondary objective...

Cite
Mokart D, Darmon M, Schellongowski P, et al. Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status. Ann Intensive Care. 2020;10(1):146doi: 10.1186/s13613-020-00764-7.
Mokart, D., Darmon, M., Schellongowski, P., Pickkers, P., Soares, M., Rello, J., Bauer, P. R., van de Louw, A., Lemiale, V., Taccone, F. S., Martin-Loeches, I., Salluh, J., Rusinova, K., Mehta, S., Antonelli, M., Kouatchet, A., Barratt-Due, A., Valkonen, M., Landburg, P. P., Bukan, R. B., Pène, F., Metaxa, V., Burghi, G., Saillard, C., Nielsen, L. B., Canet, E., Bisbal, M., Azoulay, E. (2020). Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status. Annals of intensive care, 10(1), 146. https://doi.org/10.1186/s13613-020-00764-7
Mokart, Djamel, et al. "Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status." Annals of intensive care vol. 10,1 (2020): 146. doi: https://doi.org/10.1186/s13613-020-00764-7
Mokart D, Darmon M, Schellongowski P, Pickkers P, Soares M, Rello J, Bauer PR, van de Louw A, Lemiale V, Taccone FS, Martin-Loeches I, Salluh J, Rusinova K, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Landburg PP, Bukan RB, Pène F, Metaxa V, Burghi G, Saillard C, Nielsen LB, Canet E, Bisbal M, Azoulay E. Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status. Ann Intensive Care. 2020 Oct 22;10(1):146. doi: 10.1186/s13613-020-00764-7. PMID: 33090310; PMCID: PMC7581668.
Copy Download .nbib Format: NLM
Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019.

Annals of intensive care

Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A.
PMID: 35024972
Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3.

BACKGROUND: Duration of invasive mechanical ventilation (IMV) prior to extracorporeal membrane oxygenation (ECMO) affects outcome in acute respiratory distress syndrome (ARDS). In coronavirus disease 2019 (COVID-19) related ARDS, the role of pre-ECMO IMV duration is unclear. This single-centre, retrospective...

Cite
Hermann M, Laxar D, Krall C, et al. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022;12(1):6doi: 10.1186/s13613-022-00980-3.
Hermann, M., Laxar, D., Krall, C., Hafner, C., Herzog, O., Kimberger, O., Koenig, S., Kraft, F., Maleczek, M., Markstaller, K., Robak, O., Rössler, B., Schaden, E., Schellongowski, P., Schneeweiss-Gleixner, M., Staudinger, T., Ullrich, R., Wiegele, M., Willschke, H., Zauner, C., & Hermann, A. (2022). Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Annals of intensive care, 12(1), 6. https://doi.org/10.1186/s13613-022-00980-3
Hermann, Martina, et al. "Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019." Annals of intensive care vol. 12,1 (2022): 6. doi: https://doi.org/10.1186/s13613-022-00980-3
Hermann M, Laxar D, Krall C, Hafner C, Herzog O, Kimberger O, Koenig S, Kraft F, Maleczek M, Markstaller K, Robak O, Rössler B, Schaden E, Schellongowski P, Schneeweiss-Gleixner M, Staudinger T, Ullrich R, Wiegele M, Willschke H, Zauner C, Hermann A. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022 Jan 13;12(1):6. doi: 10.1186/s13613-022-00980-3. PMID: 35024972.
Copy Download .nbib Format: NLM
Critical care management of chimeric antigen receptor T-cell therapy recipients.

CA: a cancer journal for clinicians

Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M.
PMID: 34613616
CA Cancer J Clin. 2022 Jan;72(1):78-93. doi: 10.3322/caac.21702. Epub 2021 Oct 06.

Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapeutic treatment concept that is changing the treatment approach to hematologic malignancies. The development of CAR T-cell therapy represents a prime example for the successful bench-to-bedside translation of advances in...

Cite
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, et al. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2021;72(1):78-93doi: 10.3322/caac.21702.
Shimabukuro-Vornhagen, A., Böll, B., Schellongowski, P., Valade, S., Metaxa, V., Azoulay, E., & von Bergwelt-Baildon, M. (2022). Critical care management of chimeric antigen receptor T-cell therapy recipients. CA: a cancer journal for clinicians, 72(1), 78-93. https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen, Alexander, et al. "Critical care management of chimeric antigen receptor T-cell therapy recipients." CA: a cancer journal for clinicians vol. 72,1 (2022): 78-93. doi: https://doi.org/10.3322/caac.21702
Shimabukuro-Vornhagen A, Böll B, Schellongowski P, Valade S, Metaxa V, Azoulay E, von Bergwelt-Baildon M. Critical care management of chimeric antigen receptor T-cell therapy recipients. CA Cancer J Clin. 2022 Jan;72(1):78-93. doi: 10.3322/caac.21702. Epub 2021 Oct 06. PMID: 34613616.
Copy Download .nbib Format: NLM
Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit.

Annals of intensive care

Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, Zauner C, Heinz G, Schellongowski P, Kluge S, Trauner M, Fuhrmann V.
PMID: 27392655
Ann Intensive Care. 2016 Dec;6(1):61. doi: 10.1186/s13613-016-0162-4. Epub 2016 Jul 08.

BACKGROUND: Hypoxic hepatitis (HH) is a frequent and potentially life-threatening event typically occurring in critically ill patients as a consequence of hemodynamic impairment. While acute kidney injury (AKI) has been well described in patients with acute liver failure, incidence...

Cite
Drolz A, Horvatits T, Roedl K, et al. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care. 2016;6(1):61doi: 10.1186/s13613-016-0162-4.
Drolz, A., Horvatits, T., Roedl, K., Rutter, K., Staufer, K., Haider, D. G., Zauner, C., Heinz, G., Schellongowski, P., Kluge, S., Trauner, M., & Fuhrmann, V. (2016). Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Annals of intensive care, 6(1), 61. https://doi.org/10.1186/s13613-016-0162-4
Drolz, Andreas, et al. "Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit." Annals of intensive care vol. 6,1 (2016): 61. doi: https://doi.org/10.1186/s13613-016-0162-4
Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, Zauner C, Heinz G, Schellongowski P, Kluge S, Trauner M, Fuhrmann V. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care. 2016 Dec;6(1):61. doi: 10.1186/s13613-016-0162-4. Epub 2016 Jul 08. PMID: 27392655; PMCID: PMC4938842.
Copy Download .nbib Format: NLM
Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians.

Memo

Schellongowski P, Kiehl M, Kochanek M, Staudinger T, Beutel G.
PMID: 27069513
Memo. 2016;9:39-44. doi: 10.1007/s12254-016-0256-6. Epub 2016 Mar 08.

Every sixth to eighth European intensive care unit patient suffers from an underlying malignant disease. A large proportion of these patients present with cancer-related complications. This review explains why the prognosis of critically ill cancer patients has improved substantially...

Cite
Schellongowski P, Kiehl M, Kochanek M, et al. Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians. Memo. 2016;9:39-44doi: 10.1007/s12254-016-0256-6.
Schellongowski, P., Kiehl, M., Kochanek, M., Staudinger, T., Beutel, G. (2016). Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians. Memo, 939-44. https://doi.org/10.1007/s12254-016-0256-6
Schellongowski, Peter, et al. "Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians." Memo vol. 9 (2016): 39-44. doi: https://doi.org/10.1007/s12254-016-0256-6
Schellongowski P, Kiehl M, Kochanek M, Staudinger T, Beutel G. Intensive care for cancer patients: An interdisciplinary challenge for cancer specialists and intensive care physicians. Memo. 2016;9:39-44. doi: 10.1007/s12254-016-0256-6. Epub 2016 Mar 08. PMID: 27069513; PMCID: PMC4786590.
Copy Download .nbib Format: NLM
Showing 13 to 19 of 19 entries